SCHEMBL6972156

SCHEMBL6972156

O=c1cc(-c2ccc(Oc3ccccc3)cc2)nc(S)[nH]1

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
XDH P47989 6/20 0.70
GPR84 Q9NQS5 1/20 0.54
MCL1 Q07820 4/20 0.48
KDM4E B2RXH2 3/20 0.46
GSTP1 P09211 1/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
HSD17B10 Q99714 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MAPT P10636 1/20 0.45
GSK3B P49841 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6969615 0.86 XDH (0.66) XDHKDM4EMEN1ALDH1A1MAPK1
SCHEMBL14801814 0.71 MCL1 (0.71) XDHMCL1GSTP1MEN1MAPK1
SCHEMBL6974659 0.70 XDH (0.46) XDHMEN1ALDH1A1MAPK1KMT2A
SCHEMBL28133262 0.70 GSK3B (0.65) XDHKDM4EMEN1ALDH1A1MAPK1
SCHEMBL11146636 0.69 CYP1A2 (0.71) XDHGPR84GSTP1MEN1KMT2A
SCHEMBL13203160 0.69 MCL1 (0.69) XDHMCL1KDM4EMEN1ALDH1A1
SCHEMBL21882451 0.69 MCL1 (0.69) XDHMCL1KDM4EMEN1ALDH1A1
SCHEMBL21882397 0.69 MCL1 (0.69) XDHMCL1KDM4EMEN1ALDH1A1
SCHEMBL20220304 0.69 MAPK1 (0.68) XDHMCL1KDM4EMEN1ALDH1A1
SCHEMBL20220275 0.69 MAPK1 (0.68) XDHMCL1KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 WO disclosed